CDH1 and prostate cancer: These results also support the development of inhibitors targeting these ncRNAs for gene-selective transcriptional reprogramming28, 34, 60, 61, since knockdown of S-paRNA reactivates CDH1 expression in prostate cancer cells and impairs their proliferative, clonogenic and stem-likeness.